期刊文献+

川芎嗪对肝硬化大鼠瘦素及其受体表达的干预作用 被引量:1

Intervention of Tetramethylpyrazine on Expression of Leptin and its Receptor in Cirrhotic Rats
下载PDF
导出
摘要 背景:瘦素与肝纤维化关系密切,但其在肝硬化形成过程中的作用机制不明。目前使用的抗肝硬化药物疗效均不满意。目的:观察瘦素及其功能性受体(Ob-Rb)在大鼠肝硬化形成过程中的表达变化,以及川芎嗪对两者表达的干预作用,探讨川芎嗪抗肝纤维化的作用机制。方法:诱导CCl_4大鼠肝纤维化模型。川芎嗪预防组和治疗组分别于实验第1d和第31d开始予川芎嗪每天10mg/100g体重干预。于12周内分批处死各组大鼠。以逆转录聚合酶链反应(RT-PCR)检测肝组织瘦素和Ob-Rb mRNA表达,以免疫组化方法检测瘦素和Ob-Rb的表达和定位,同时行血清透明质酸(HA)水平检测和肝内胶原定量分析。结果:正常肝组织中有少量瘦素和Ob-Rb mRNA表达,随着肝硬化的形成,两者表达逐渐增加,与血清HA水平和肝内胶原含量呈正相关。肝硬化模型组汇管区、纤维间隔、小叶内血管、胆管、肝窦周围瘦素和Ob-Rb表达明显增加,表达强度从第3~12周呈递增趋势。川芎嗪预防组和治疗组瘦素和Ob-Rb及其mRNA表达均低于肝硬化模型组,两组血清HA水平和肝内胶原含量亦显著低于肝硬化模型组。结论:瘦素和Ob-Rb在肝硬化形成过程中发挥重要作用。川芎嗪能下调CCl_4肝纤维化大鼠肝组织瘦素和Ob-Rb的表达,这可能是其抗肝纤维化的作用机制之一。 Background:Studies have shown that leptin is closely correlated with liver fibrosis, however, its mechanism in the development of liver cirrhosis is not clear yet. The efficacy of anti-cirrhotic agents used clinically is not satisfactory. Aims: To observe the dynamic expression of leptin and its long form receptor (Ob-Rb) in the developing process of liver cirrhosis in rats, and the interventional effect of tetramethylpyrazine (TMP) on the expression of leptin and Ob-Rb, so as to investigate the mechanism of TMP against liver fibrosis. Methods: 60% CCl4 was injected subcutaneously to induce liver fibrosis model in rats. The animals in prevention and treatment groups were given TMP 10 mg/100 g per day from the 1st and 31st day of induction, respectively. All the animals in the experimental groups were sacrificed within 12 weeks in batch. Expression of leptin and Ob-Rb mRNA in liver tissue was detected by reverse transcriptase polymerase chain reaction (RT-PCR), and the expression and distribution of leptin and Ob-Rb by immunohistochemistry. Measurements of serum level of hyaluronic acid (HA) and quantitative analysis of collagen in liver tissue were conducted simultaneously. Results: Leptin and Ob-Rb mRNA expressed slightly in the normal liver tissue, and increased gradually after CCL injection, which were positively correlated with the serum level of HA and collagen amount in liver tissue. Up-regulated expression of leptin and Ob-Rb was observed in the portal area, septum, perivascular and perisinusoidal areas of hepatic lobule, and bile duct in cirrhotic model group, the intensity of expression increased in a time-dependent manner from the 3rd to 12th week. Expression of leptin and Ob-Rb and its mRNA in TMP prevention and treatment groups decreased significantly when compared with those in the cirrhotic model group, so did the serum HA level and collagen amount in liver tissue. Conclusions: Leptin and Ob-Rb are involved in the development of liver cirrhosis. Inhibition of hepatic leptin and Ob-Rb might be one of the mechanisms of TMP against liver fibrosis in CCL-induced fibrotic rats.
出处 《胃肠病学》 2007年第10期593-597,共5页 Chinese Journal of Gastroenterology
基金 浙江省中医药管理局基金项目(2005C147)
关键词 瘦素 受体 瘦素 川芎嗪 肝硬化 实验性 纤维化 Leptin Receptors, Leptin TETRAMETHYLPYRAZINE Liver Cirrhosis, Experimental Fibrosis
  • 相关文献

参考文献9

  • 1Crespo J, Rivero M, Fabrega E, et al. Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis. Dig Dis Sci, 2002, 47 (7): 1604-1610.
  • 2Piche T, Vandenbos F, Abakar-Mahamat A, et al. The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C. J Viral Hepat, 2004, 11 (1): 91-96.
  • 3姬成伟,刘晋敏,李亮成,李霞,李素梅.川芎嗪阻抑大鼠肝纤维化作用实验研究[J].山西医科大学学报,2003,34(4):293-295. 被引量:32
  • 4李善高,王天才,梁扩寰,程向东.四甲基吡嗪对实验性大鼠肝纤维化防治作用的研究[J].中华消化杂志,1998,18(3):153-155. 被引量:9
  • 5Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer, 1996, 73 (7): 931-934.
  • 6Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372 (6505): 425-432.
  • 7Potter JJ, Womack L, Mezey E, et al. Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem Biophys Res Commun, 1998, 244 (1): 178-182.
  • 8Honda H, Ikejima K, Hirose M, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology, 2002, 36 (1): 12-21.
  • 9Leclercq IA, Farrell GC, Schriemer R, et al. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol, 2002, 37 (2): 206-213.

二级参考文献14

  • 1吴孟超 杨广顺.大鼠肝硬变模型复捌的研究[J].中华实验外科杂志,1984,1(4):145-147.
  • 2Roeb E, Graeve L, Hoffmoan R, et al. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures[J]. Hepatology, 1993, 18(6):1437--1442.
  • 3Hayasaka A, Saisho H. Serum markers as tools to monitor liver fibrosis[J]. Digestion, 1998, 59(4): 381--384.
  • 4Britton RS, Bacon BR. Role of free radicals in liver diseases and hepatic fibrosls[J]. Hepatogastroenterology, 1994, 41(4): 343--348.
  • 5Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide[J]. Lancet, 1991, 337(8744):776-778.
  • 6邹爱萍,病理生理学报,1995年,1期,14页
  • 7樊光祥,中国中西医结合杂志,1994年,14卷,26页
  • 8黄建邦,中国中西医结合杂志,1994年,14卷,607页
  • 9陈祥银,中华结核和呼吸杂志,1987年,10卷,152页
  • 10王玉良,中国中西医结合杂志,1985年,5期,291页

共引文献39

同被引文献24

  • 1栗明,栗德林,汤大北.芪玄益心胶囊对糖尿病大鼠急性缺血心肌瘦素mRNA表达的影响[J].中医药学报,2008,36(1):28-30. 被引量:2
  • 2洪鸣鸣,张月芳,冷建杭,陈瑾,王立建.瘦素与高脂血症痰浊证及脏腑相关性研究[J].中国中医药科技,2007,14(3):147-148. 被引量:4
  • 3唐敏,程开诚,王光富,宫育恒,苏海.卡托普利与缓释硝苯地平对高血压患者血清瘦素的影响[J].中华高血压杂志,2007,15(7):579-582. 被引量:5
  • 4Zhang Y,Proenca R,Maffei M,et al.Positional cloning of the mouse obese gene and its human homologue[J].Nature,1994,372(6505):425-432.
  • 5Wallace AM,McMahon AD,Packard CJ,et al.Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study(WOSCOPS)[J].Circulation,2001,104(25):3052-3056.
  • 6Cohen MM.Role of leptin in regulating appetite,neuroendocrine function,and bone remodeling[J].Am J Med Genet A,2006,140(5):515-524.
  • 7Lieb W,Sullivan LM,Harris TB,et al.Plasma leptin levels and incidence of heart failure,cardiovascular disease,and total mortality in elderly individuals[J].Diabetes Care,2009,32(4):612-616.
  • 8Straznicky NE,Lambert EA,Lambert GW,et al.Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome[J].J Clin Endocrinol Metab,2005,90(11):5998-6005.
  • 9Nakata M,Maruyama I,Yada T.Leptin potentiates ADP-induced[Ca2+] (i) increase via JAK2 and tyrosine kinases in a megakaryoblast cell line[J].Diabetes Res Clin Pract,2005,70(3):209-216.
  • 10Arch JR.Central regulation of energy balance:Inputs,outputs and leptin resistance[J].Proc Nutr Soc,2005,64(1):39-46.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部